TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 5 | 17 | 15 | 1 | 9 | 9 | 9 | 
| P | %wins | 100 | 100 | 100 | 50 | 50 | 50 | 75 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/18 20:30  | 12/10/18  | AGE | Agex Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | West Michael D | CA | DO | CEO | P | 15 | 3.86 | 0 | 4 | 35 | 15 | D | ||||||||||||||
8/23/17 19:23  | 8/22/17  | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | West Michael D | CA | DO | Co-CEO | P | 5 | 2.60 | 0 | 2 | 0 | 883 | D | ||||||||||||||
5/31/12 17:42  | 5/31/12  | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | West Michael D | CA | DO | CEO | P | 40 | 4.05 | 0 | 10 | 10 | 110 | D | -33 | -21 | -2 | -18 | 5 | 8 | 2 | -4 | 5 | 7 | 9 | -2 | -9 | 19 | 
6/23/11 06:10  | 6/22/11  | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | West Michael D | CA | DO | CEO | P | 44 | 4.40 | 1 | 10 | 14 | 80 | D | 93 | -31 | -54 | -41 | -26 | -10 | 5 | -2 | 5 | 26 | 21 | 4 | 26 | -1 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |